Cure My Disease

Don't miss your cure!

 Log in / Sign up

Personal support boosts heart recovery in women

NCT ID NCT04693988

Disease control Sponsor: University of Vermont Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study tests whether a case manager—who provides phone support, a home visit, and lifestyle counseling—can help women attend cardiac rehabilitation after a heart attack or heart surgery. Cardiac rehab is proven to reduce mortality and improve quality of life, but women are less likely to attend than men. The trial enrolls women with qualifying heart conditions who live in the Burlington, Vermont area and tracks whether they attend rehab sessions within four months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Case management (phone support, home visit, counseling)
What this could lead to
If it works, this approach could help more women attend cardiac rehab, leading to better recovery and fewer future heart problems.
What could go wrong
This is a small, early-stage study. The case management may not significantly improve attendance, and results may not apply to all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

114 people

The number who actually took part.

Started

Jan 2021

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \- Inclusion Criteria: 1. A cardiac rehabilitation qualifying condition including: A recent myocardial infarction or coronary revascularization or heart valve replacement or repair, stable angina, or congestive heart failure (ejection fraction \<35%) 2. Lives in and plans to remain in the greater Burlington, Vermont area for the next year. Exclusion Criteria: 1. Severe dementia 2. Advanced cancer, advanced frailty, or other longevity-limiting systemic disease 3. Severe life threatening ventricular arrhythmias unless adequately controlled (e.g. intracardiac defibrillator) 4. Exercise-limiting non-cardiac disease such as severe arthritis, past stroke leading to paralysis 5. Participation in cardiac rehab within the past year

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac rehabilitation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congestive heart failure myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac rehabilitation

Contacts and locations

Locations

  • University of Vermont Medical Center

    Burlington, Vermont, 05405, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.